- Home
- AMBC vs PHAR Comparison
AMBC vs PHAR Comparison
Compare AMBC & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- PHAR
- Stock Information
- Founded
- AMBC 1991
- PHAR 1988
- Country
- AMBC United States
- PHAR Netherlands
- Employees
- AMBC N/A
- PHAR N/A
- Industry
- AMBC Property-Casualty Insurers
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- PHAR Health Care
- Exchange
- AMBC Nasdaq
- PHAR Nasdaq
- Market Cap
- AMBC 635.7M
- PHAR 679.0M
- IPO Year
- AMBC 1991
- PHAR N/A
- Fundamental
- Price
- AMBC $11.22
- PHAR $9.10
- Analyst Decision
- AMBC Strong Buy
- PHAR Strong Buy
- Analyst Count
- AMBC 2
- PHAR 3
- Target Price
- AMBC $17.00
- PHAR $27.00
- AVG Volume (30 Days)
- AMBC 461.3K
- PHAR 6.7K
- Earning Date
- AMBC 02-25-2025
- PHAR 03-13-2025
- Dividend Yield
- AMBC N/A
- PHAR N/A
- EPS Growth
- AMBC N/A
- PHAR N/A
- EPS
- AMBC N/A
- PHAR N/A
- Revenue
- AMBC $398,000,000.00
- PHAR $285,745,000.00
- Revenue This Year
- AMBC N/A
- PHAR $20.08
- Revenue Next Year
- AMBC N/A
- PHAR $9.22
- P/E Ratio
- AMBC N/A
- PHAR N/A
- Revenue Growth
- AMBC 22.46
- PHAR 30.64
- 52 Week Low
- AMBC $10.12
- PHAR $6.65
- 52 Week High
- AMBC $18.45
- PHAR $13.20
- Technical
- Relative Strength Index (RSI)
- AMBC 36.41
- PHAR 46.44
- Support Level
- AMBC $11.09
- PHAR $9.37
- Resistance Level
- AMBC $11.67
- PHAR $10.01
- Average True Range (ATR)
- AMBC 0.41
- PHAR 0.55
- MACD
- AMBC -0.03
- PHAR -0.14
- Stochastic Oscillator
- AMBC 29.10
- PHAR 16.26
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.